Sodium Deoxycholate: From Bile Salt Structure to Laboratory Use

Introduction to Sodium Deoxycholate (Na-DOC) as an Anionic Surfactant

Sodium deoxycholate (Na-DOC, CAS 302-95-4) is the sodium salt of deoxycholic acid, a naturally occurring secondary bile acid in mammals. It is produced in the intestine through bacterial 7α-dehydroxylation of cholic acid, one of the major primary bile acids synthesized in the liver from cholesterol. As a bile-salt detergent, sodium deoxycholate occupies a unique place among surfactants: unlike classical linear anionics such as sodium dodecyl sulfate (SDS), Na-DOC has a rigid steroidal backbone that creates a “facial amphiphile”—one side of the molecule is decorated with hydroxyl and carboxyl groups (hydrophilic face), while the opposite side presents a hydrophobic, methyl-rich plane.

Let me break the structure down step by step for you to easy to understand.

• The Steroidal (cholane) backbone：the “cholane” skeleton is a rigid four-ring steroid framework — like four fused hexagons/pentagons in a flat plane.
• At the 3-position and 12-position of the steroid ring, Na-DOC has hydroxyl groups pointing toward the same side. These are polar, water-loving handles sticking out of one face of the plate.
• At the end of the side chain (carbon 24), Na-DOC has a carboxyl group (–COOH). In sodium deoxycholate, this is deprotonated (–COO⁻) and paired with Na⁺, making it strongly ionic and water-soluble. This carboxylate is also on the polar face of the molecule, near the hydroxyl groups.
• The “two-faced” polarity (facial amphiphilicity): One face of the steroid plate has all the polar groups (–OH, –COO⁻). The other face is smooth and covered with methyl groups (–CH₃), which are nonpolar and greasy.

The figure represents that sodium deoxycholate (Na-DOC) is not a simple “head-tail” surfactant (like SDS), but instead a “facial amphiphile” — meaning one face (side) of the rigid steroid plate is hydrophilic, while the opposite face is hydrophobic.

Sodium Deoxycholate (Na-DOC) carried by Aladdin

Aladdin catalog	Product name	Grade & Purity
S485305	Sodium deoxycholate	Suitable for manufacturing of diagnostic kits and reagents
S423127	Sodium deoxycholate	10mM in DMSO
S104198	Sodium deoxycholate	≥98%
S274361	Sodium deoxycholate	High-purity
S579505	Sodium deoxycholate	≥97%

Sodium Deoxycholate (Na-DOC) — Structure–Property–Performance Table

Category	Parameter / Feature	Value / Data	Structural Basis	How It Connects to Performance
Core identifiers	Molecular formula / MW/CAS number	C24H39O4Na / 414.56 g·mol⁻¹ /302-95-4	Steroidal cholane skeleton + Na⁺ carboxylate	Defines dosing, micelle size, and stoichiometric use in buffers.
Acid–base property	pKa(free acid)	~6.2	C-24 carboxyl group	Ionized above pH ~7 → anionic surfactant;  protonated below pH ~5.5 → precipitation.
Amphiphilicity	HLB	~16	“Facial amphiphile”: hydroxyl + carboxylate on one side, hydrophobic face opposite	Places SDC in highly hydrophilic detergent range, explaining use in aqueous lysis buffers and protein digestions.
Micellization	CMC	~2–6 mM (0.08–0.25% w/v, 25 °C)	Steroid backbone restricts micelle growth → small aggregation number	Ensures micelle formation at low % (0.1–0.5%); reversible solubilization avoids excessive denaturation.
	Aggregation number	~3–12	Flat, rigid steroid plane prevents large spherical packing	Small, dynamic micelles → rapid lipid/protein exchange, ideal for membrane protein solubilization.
	Micelle mol. wt.	~1.2–4.9 kDa	Flat, rigid steroid plane	Important for predicting size-exclusion/filtration behavior.
Solubility	Solubility (H₂O, 20 °C)	≥ 274–333 g·L⁻¹	Na⁺salt form stabilizes dissociation; free acid poorly soluble	High solubility allows concentrated stock solutions; pH-sensitive precipitation enables removal by acidification.
	Solution pH (20 g/L)	~7.5–9.0	Carboxylate buffering	Provides self-buffering mild alkalinity; compatible with neutral–slightly basic buffers.
Colloidal behavior	Mixed micelles	Forms with phospholipids, cholesterol, other surfactants	Facial amphiphilicity drives non-ideal mixing	Enables custom surfactant blends (e.g., RIPA, proteomics workflows).
	Salt effects	Added NaCl lowers CMC, increases micelle size	Charge-screening of carboxylates	Allows tuning harshness for selective protein solubilization.
Performance links	Extraction strength	Effective at 0.1–2% (w/v); RIPA uses 0.5%	Micelles disrupt lipid bilayers	Balanced harshness: extracts membrane proteins without over-denaturation.
	Proteomics cleanup	Acid precipitation or PTS (ethyl acetate extraction) removes >99% SDC	pH-sensitive solubility	MS-compatible after easy surfactant removal.
	Microbiological selectivity	1–5 g·L⁻¹ in DCA/XLD media inhibits Gram-positives	Bile-salt mimicry	Selective growth medium component; suppresses sensitive flora.

Applications and Laboratory Considerations of Sodium Deoxycholate (Na-DOC)

Application	Typical Use / Data	Key Laboratory Considerations
Cell lysis / protein extraction	0.5% (w/v) in RIPA buffer with NP-40 + SDS	Below CMC (~2–6 mM) = ineffective; excessive levels denature proteins. Balance needed for efficient yet gentle extraction.
Proteomics digestion workflows	0.1–2% Na-DOC enhances trypsin activity and solubilizes hydrophobic proteins	Acidification (pH ≤ 5.5) precipitates DOC — useful for removal
Phase-Transfer Surfactant (PTS) protocols	Na-DOC + lauroylsarcosinate; ethyl acetate extraction removes >99% detergent post-digestion	Requires strict pH control and handling of organic solvents; improper phase separation risks peptide loss.
Microbiological selective media (DCA, XLD, etc.)	1–5g·L⁻¹ Na-DOC inhibits Gram-positives, allows enteric Gram-negatives	Too little → weak selectivity; too much → suppresses target organisms. Must be tuned to recipe.
Endotoxin removal (Detoxi-Gel, etc.)	Strips lipopolysaccharides (LPS) from affinity columns	Overexposure may strip or destabilize sensitive proteins along with LPS.
Virology / lipid disruption	Micelles disrupt enveloped viruses, extract lipids	Strong detergent action risks damaging membrane proteins or losing functional complexes.
General handling / storage	Highly soluble (≥ 274–333 g·L⁻¹ in H2O, 20 °C); stable stocks at 4 °C	GHS07 hazard (H302, H315, H319): harmful if swallowed, irritant. Use gloves, goggles, fume hood. Avoid Mn²⁺ contamination.

Sodium Deoxycholate (Na-DOC) vs. Sodium Cholate (Na-Cholate)

Feature	Sodium Deoxycholate (Na-DOC)	Sodium Cholate (Na-Cholate)	Key Difference & Impact
Parent acid	Deoxycholic acid (secondary bile acid)	Cholic acid (primary bile acid)	Deoxycholic acid is formed by bacterial 7α-dehydroxylation of cholic acid in the gut.
Hydroxyl groups	Two hydroxyls: 3α, 12α	Three hydroxyls: 3α, 7α, 12α	Extra hydroxyl group in cholic acid makes it more hydrophilic.
Hydrophobicity	More hydrophobic (fewer OH groups)	More hydrophilic (extra OH group)	Na-DOC is a stronger membrane disruptor; Na-Cholate is milder.
CMC	~2–6 mM (higher, less stable micelles)	~5–15 mM (varies, slightly higher depending on conditions)	Both high compared to SDS, but Na-DOC forms slightly larger, more effective micelles.
Micelle aggregation number	Low (~3–12)	Similar but slightly smaller due to higher hydrophilicity	Na-DOC tends to interact more strongly with lipids.
Applications	Protein extraction (RIPA), proteomics (phase-transfer surfactant), microbiological selective agent	Gentler solubilization of membrane proteins, stabilizing bile salt transport studies, crystallization additives	Choice depends on balance between solubilization vs. preservation.
Physiological role	Major secondary bile salt in humans; aids in lipid digestion, but also associated with cytotoxicity in excess	Major primary bile salt in liver secretion; central to fat digestion and absorption	Reflects metabolic stage: Na-Cholate is liver-synthesized, Na-DOC is gut-modified.

References:

1. Sigma-Aldrich (Merck). Sodium deoxycholate, ≥97% (titration), CAS 302-95-4, Product Information Sheet. Merck KGaA; 2024. Available from: https://www.sigmaaldrich.com

2. Thermo Fisher Scientific. Sodium deoxycholate, Product Datasheet. Thermo Fisher; 2024. Available from: https://www.thermofisher.com

3. RSC Advances. Effect of additives on sodium deoxycholate micellization. RSC Adv. 2016;6(94):91903–91912.

4. He L, Diedrich J, Chu Y, Yates JR. Extracting accurate precursor information for tandem mass spectra by rawconverter. Anal Chem. 2015;87(22):11361–11367.

5. Masuda T, Tomita M, Ishihama Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J Proteome Res. 2008;7(2):731–740.

6. Hara T, Takahashi N, Yoshimura Y, et al. Sodium deoxycholate-assisted tryptic digestion combined with phase transfer surfactant extraction for enhanced proteome analysis. Proteomics. 2013;13(5):876–882.

7. Atlas RM. Handbook of Microbiological Media. 4th ed. CRC Press; 2010. (for DCA and bile salt agar formulations).

8. Levine M. Differentiation of enteric bacteria on deoxycholate agar. J Bacteriol. 1918;3(5):401–420.

9. Thermo Fisher Scientific. Detoxi-Gel Endotoxin Removing Columns, Protocol and Applications. Thermo Fisher; 2024.

10. Small DM. The physical chemistry of cholanic acids. J Lipid Res. 1968;9(3):297–318.

Aladdin: https://www.aladdinsci.com/